FDA Approves Expanded Use of Lilly's Forteo [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
Links shared publicly online about this topic.
- 1,875total visits
FDA Approves Expanded Use of Lilly's Forteo [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis
Forteo (teriparatide) is used to treat glucocorticoid-induced osteoporosis. Includes Forteo side effects, interactions and indications.
View full resource at drugs.com
Tags: Osteoporosis, Osteoporosis Medication, FDA, Forteo
Most Recently Shared on July 24, 2009 at 12:56 am By:
FDA Approves Forteo for Glucocorticoid-Induced Osteoporosis - http://bit.ly/GUN2r
Advertisement
